About 3700 new cases of endometrial cancer are reported in the United Kingdom each year. The incidence of the disease increases considerably during the fifth decade of life and reaches a peak between the ages of 60 (1 -95) . The values obtained in the two groups of women with postmenopausal bleeding were logarithmically transformed to approximate normal distributions, and the overlap was estimated by using the means and standard deviations. We calculated that a cut off value of 2-00 would give a detection rate of 99 0% with a false positive rate of 2-6%. Consequently the calculated predictive value of a positive result of screening in women with postmenopausal bleeding (assuming the prevalence of endometrial cancer to be 10%) would be 80-9% and the predictive value of a negative result would be 99-9%. The odds ratio for the diagnosis of cancer from subsequent examination of an endometrial biopsy specimen would be reduced from 1:9 against to about 5: 1 in favour.
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We also determined the pulsatility index in the tumour in 10 women with endometrial cancer. The values obtained were similar to the uterine arterial index in three women and lower in seven (table).
Comment
We believe that these preliminary data show the great potential of transvaginal pulsed Doppler ultrasonography, particularly with colour flow imaging. Our findings and those of others4 suggest that indices of intratumoral blood flow will be even more sensitive markers of endometrial cancer than those of uterine arterial blood flow. In contrast, measurements of endometrial (or tumoral) thickness in the same women (taking a cut off value of 0-5 cm as the upper limit of normal) yielded a rate of detection of cancer of 99% but a false positive rate of 41%. We are investigating other factors that may affect uterine blood flow-for example, fibroids, hyperplasia, or infection. We are also collecting data to assess whether colour flow imaging might be used to screen women without symptoms of endometrial cancer. The ultimate aim is to detect the disease at an early stage when surgery might reduce the mortality (currently about 1050 women die of the disease each year in the United Kingdom). BMJ VOLUME 301
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